News

Oculis Holding AG Announces Participation in Investor Conferences

Oculis Holding AG Announces Participation in Investor Conferences

Oculis Holding AG Set for Upcoming Investor Conferences

Oculis Holding AG (Nasdaq: OCS) is preparing to showcase its innovative approaches in the biopharmaceutical industry through participation in several crucial investor conferences. As a cutting-edge company, Oculis is dedicated to addressing unmet medical needs in the realms of ophthalmic and neuro-ophthalmic diseases.

Key Conference Participation Details

The first significant event on the agenda is the Goldman Sachs Annual Healthcare Conference, scheduled for June 9-11 in Miami. On the second day of the conference, Oculis' Chief Executive Officer, Riad Sherif, MD, will participate in a fireside chat on June 10th from 9:20 to 9:55am ET, offering insight into the company's strategic vision and innovative pipeline.

Further Engagement at J.P. Morgan Conference

Following the Goldman Sachs event, Dr. Sherif will also represent Oculis at the J.P. Morgan European Healthcare Conference on June 12 in London. His attendance underscores Oculis' commitment to engaging with investors and discussing its growth and future potential within the biopharmaceutical sector.

Opportunities for One-on-One Meetings

During both conferences, Oculis will be available for one-on-one meetings with potential investors. Interested participants are encouraged to reach out to their respective representatives at the sponsoring institutions for meeting arrangements. These individual sessions can provide deeper insights into Oculis' innovative projects and future endeavors in the healthcare field.

Recent Developments and Company Innovations

Oculis has been making strides with its diverse pipeline of product candidates aimed at tackling significant health challenges. Among these innovations is OCS-01, a topical eye drop aimed at diabetic macular edema (DME), which reflects Oculis' focus on developing effective treatments for prevalent eye conditions. Another promising candidate, Privosegtor (OCS-05), serves as a neuroprotective option for acute optic neuritis and has potential applications in treating other neuro-ophthalmic diseases.

Exploring Other Product Developments

Moreover, Licaminlimab (OCS-02), a topical biologic anti-TNF? eye drop for dry eye disease (DED), represents the company’s commitment to providing novel therapies for conditions that significantly affect patients' quality of life. Such innovations place Oculis at the forefront of biopharmaceutical advancements.

Company Overview

Headquartered in Switzerland, Oculis operates globally, including key operations in both the U.S. and Iceland. The management team's extensive experience and successful track record provide a solid foundation for the company’s innovation-driven approach. Oculis is committed to developing medicines that are not only effective but also transformative in the treatment of ocular diseases.

Investor and Media Contacts

For interested investors, the dedicated investor relations team at Oculis, particularly Ms. Sylvia Cheung, CFO, is a pivotal contact point. For more formal inquiries or media relations, reaching out to the ICR Healthcare team can provide additional information regarding the company’s initiatives and press materials.

Frequently Asked Questions

What is Oculis Holding AG focused on?

Oculis is a biopharmaceutical company dedicated to developing innovations that address ophthalmic and neuro-ophthalmic diseases.

When will Oculis participate in investor conferences?

The company will participate in the Goldman Sachs Annual Healthcare Conference and the J.P. Morgan European Healthcare Conference in June.

Who is Oculis's CEO?

The Chief Executive Officer of Oculis is Riad Sherif, MD, who is actively involved in investor discussions during conferences.

What are some of Oculis's innovative products?

Oculis’s innovative products include OCS-01 for diabetic macular edema, Privosegtor (OCS-05) for optic neuritis, and Licaminlimab (OCS-02) for dry eye disease.

How can investors contact Oculis for more information?

Investors can connect with Oculis through their investor relations team or via dedicated media contacts for inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Haier and UEFA's Deal: A Game-Changer for Fans?

Updated Category News Views 1

A Bold Play in the Global Arena There's something big brewing on the horizon, as Haier aligns with the UEFA Champions League. From 2027 to 2031, this move isn't just about slapping a logo on a jersey. Nah, it's more than that. Haier's stepping up its game, aiming to become a real player in weaving technology and sports into the daily lives of millions. "We aim to bring...

Continue Reading
Orbis Celebrates 20 Years of Eye Care in Macau

Updated Category News Views 2

Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...

Continue Reading
Clinical Trials Services Market Set for Big Growth

Updated Category News Views 1

Eyeing a Market Surge in Clinical Trials Numbers don't lie, and they're painting a promising picture for the clinical trials services market with a solid 8% growth forecasted annually till 2031. From a modest $66.20 billion in 2026, we're looking at ballooning to a hefty $97.41 billion by 2031. What’s cooking? Let me dish it out for you. Key Drivers and Dynamics North...

Continue Reading
Charity's Bold Move: Acquiring Wayfinder for K-12 Impact

Updated Category News Views 2

Public Charity Expands Into Education Well, here's something that's bound to turn a few heads: a fast-growing public charity has just made its first acquisition in the K-12 sphere by snapping up Wayfinder. The stakes are getting interesting. When a charity starts playing in the acquisition space, you're looking at a change in strategy that deserves close attention. Why...

Continue Reading
Labcorp Faces Lawsuit: Wiretapping Accusations Surface

Updated Category News Views 0

Labcorp's Legal Tangle Unveiled One minute you're on Labcorp's website searching for medical info, the next you're caught up in a class-action legal whirlwind. Legal drama is not on any patient’s checklist, but here we are, with Labcorp knee-deep in some serious allegations. The crux of the matter points to alleged wiretapping violations, with claims that Labcorp,...

Continue Reading
Bamboo Unveils Tailored Home Insurance for Texans

Updated Category News Views 1

Adapt or Get Left Behind: The Texas Insurance Scene In a world where costs are ballooning and the pressure on the wallet grows heavier, here comes Bamboo Insurance swinging into Texas like a hopeful knight. This plucky insurer is rolling out the Texas Essential Homeowner Program, a highly adaptable, admitted policy that promises to put some power back into the hands of...

Continue Reading
AVEX Faces Lawsuit Over IPO Missteps

Updated Category News Views 0

Legal Storm Brewing with AEVEX's IPO Disclosures Whatever happened to straightforward honesty in business? AEVEX Corp. (NYSE: AVEX) might have forgotten that chapter judging by fresh allegations in their midst. Investors who bought AVEX Class A common stock between April 17 and June 4, 2026, have been hit with a curveball: a looming class action lawsuit for securities...

Continue Reading
Bybit Enhances BTC Staking Yields Amid Crypto Fluctuations

Updated Category News Views 1

An Uptick in BTC Staking Yields Seems like Bybit's got a trick up their sleeve with their latest move. They've hiked BTC staking yields from a static 0.8% up to a more attractive 1.2%. Now, if you're parked with Bitcoin in this dicey market, that's a substantial 50% leap upwards. When you think about those dreamy numbers traders like me fantasize about, it’s a juicy...

Continue Reading
MINISFORUM Strikes with New AI Powerhouses at IFA

Updated Category News Views 2

MINISFORUM's Bold Move in Edge AI Computing There's no doubt that 2026 is about AI making its way to the forefront, and MINISFORUM is moving full steam ahead. Introduced at the IFA in Berlin, MINISFORUM unveiled its latest input into the edge AI scene with the AMD Ryzen AI MAX+ PRO 495 driving the charge. Now, these aren't just ordinary upgrades, mind you. We're talking...

Continue Reading
Halloween 2026: Gemmy's Animatronics Add Thrills

Updated Category News Views 0

Halloween's New Twist with Gemmy's Animatronics Well, just when you thought Halloween couldn't get any more over the top, here comes Gemmy with their 3-foot tall animatronic characters ready to give your trick-or-treat scene that extra jolt. These aren't just any run-of-the-mill decorations. Nope, they come with a twist—an industrial-strength twist of scares and sweets...

Continue Reading

Top 5 Most Recently Viewed Articles

The Long-Term Growth Story of Keurig Dr Pepper

Updated Category News Views 388

Understanding the Growth of Keurig Dr Pepper Keurig Dr Pepper (NASDAQ: KDP) has become a significant player in the beverage market, showing remarkable growth over the past 15 years. The company has managed to outperform the market with an annualized return of 13.71%, which is a noteworthy achievement for investors. This growth story is marked by a current market...

Continue Reading
International Petroleum Corporation Shares Repurchase Update

Updated Category News Views 96

International Petroleum Corporation's Strategic Share Buyback International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) has made a significant move to enhance its capital structure by successfully buying back a total of 181,100 common shares from September 2 to 6. This action was carried out under its normal course issuer bid (NCIB) share...

Continue Reading
Clean Energy Technologies Enhances Future with Strategic Move

Updated Category News Views 142

Strategic Reverse Stock Split by Clean Energy Technologies Clean Energy Technologies, Inc. (NASDAQ: CETY), a key player in the clean energy sector, recently announced an important step towards sustaining its presence on the Nasdaq Stock Market. The company's Board of Directors approved a 1-for-15 reverse stock split that will effectively reduce the number of its...

Continue Reading
EU Packaging Rules: Duni Group Embraces New Era

Updated Category News Views 3

Regulation Shakes Up the Industry Today marks the dawn of the European Union's Packaging and Packaging Waste Regulation (PPWR), setting some tongues wagging and others rolling up sleeves. As of August 12, the gears are grinding on these new rules aimed at cutting down packaging waste across the continent. Duni Group is standing tall, embracing the chaos these changes are...

Continue Reading
Pet King Brands to Shine at GROOM'D 2025 Event

Updated Category News Views 361

Pet King Brands to Shine at GROOM'D 2025 Event The creators of ZYMOX and Oratene are set to make a mark at GROOM'D 2025. Their presence at this significant event highlights their commitment to advancing pet care and grooming excellence. GROOM'D 2025 Overview GROOM'D 2025 will take place during a weekend full of excitement and learning. The event runs from March 7 to March...

Continue Reading